High‐dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B‐cell lymphoma

programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia. PLoS One, 8, e55818. doi:10.1371/journal.pone.0055818 Daum, S., Hummel, M., Weiss, D., Peters, M., Wiedenmann, B., Schaper, F., Stein, H., Riecken, E.O. & Foss, H. (2000) Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathytype intestinal T-cell lymphoma. Digestion, 62, 60–65. Gabrilovich, D. & Nagaraj, S. (2009) Myeloidderived suppressor cells as regulators of the immune system. Nature Reviews. Immunology, 9, 162–174. Lin, Y., Gustafson, M., Bulur, P., Gastineau, D., Witzig, T. & Dietz, A. (2011) Immunosuppressive CD14 + HLA-DR(low)/monocytes in B-cell non-Hodgkin lymphoma. Blood, 117, 872–881. Poschke, I. & Kiessling, R. (2012) On the armament and appearances of human myeloidderived suppressor cells. Clinical Immunology, 144, 250–268. Rubio-Tapia, A., Kelly, D.G., Lahr, B.D., Dogan, A., Wu, T.T. & Murray, J.A. (2009) Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology, 136, 99–107. Verbeek, W., von Blomberg, B., Coupe, V., Daum, S., Mulder, C. & Schreurs, M. (2009) Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Cytometry. Part B, Clinical Cytometry, 76B, 367–374. van Wanrooij, R.L., de Jong, D., Langerak, A.W., Ylstra, B., van Essen, H.F., Heideman, D.A., Bontkes, H.J., Mulder, C.J. & Bouma, G. (2015) Novel variant of EATL evolving from mucosal cd-T-cells in a RCD type I patient. BMJ Open Gastroenterology, 2, e000026. doi: 10.1136/bmjgast-2014-000026